檢索結果 - Peter Reichardt
- Showing 1 - 20 results of 80
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Monitoring of Tumor Cell Purging After Highly Efficient Immunomagnetic Selection of CD34 Cells From Leukapheresis Products in Breast Cancer Patients: Comparison of Immunocytochemic... 由 Markus Y. Mapara, I. Körner, Martin Hildebrandt, Ralf C. Bargou, Dorothea Krahl, Peter Reichardt, Bernd Dörken
出版 1997Artigo -
13
-
14
-
15
-
16
-
17
-
18
Docetaxel and Continuous-Infusion Fluorouracil Versus Epirubicin, Cisplatin, and Fluorouracil for Advanced Gastric Adenocarcinoma: A Randomized Phase II Study 由 Peter Thuss‐Patience, Albrecht Kretzschmar, Michael Repp, D. Kingreen, Dirk Hennesser, S. Micheel, Daniel Pink, Christian W. Scholz, Bernd Dörken, Peter Reichardt
出版 2005Artigo -
19
-
20
A phase I–II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors 由 Patrick Schöffski, Peter Reichardt, Jean‐Yves Blay, Herlinde Dumez, Jeffrey A. Morgan, Isabelle Ray‐Coquard, Norbert Hollaender, Annette Jappe, George D. Demetri
出版 2010Artigo
相關主題
Medicine
Internal medicine
Oncology
Pathology
Cancer
Stromal cell
Surgery
Chemotherapy
GiST
Imatinib
Myeloid leukemia
Gastroenterology
Imatinib mesylate
Clinical trial
Sarcoma
Clinical endpoint
Adverse effect
Stromal tumor
Biology
Radiology
Randomized controlled trial
Breast cancer
Confidence interval
Phases of clinical research
Sunitinib
Environmental health
Family medicine
Hazard ratio
PDGFRA
Population